Gadolinium incorporated reconstituted chylomicron emulsion for potential application in tumor neutron capture therapy

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 62, Issue 3, 2006, Pages 275-281

  Dierling, Annie M ^a   Sloat, Brian R ^a   Cui, Zhengrong ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Biodistribution; Lipoprotein; Nanoparticles; PEG; Tumor targeting

Indexed keywords

ACETONE; CHYLOMICRON; GADOLINIUM; GADOLINIUM ACETYLACETONATE; MACROGOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; LIPOPHILICITY; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PH; TUMOR;

ANIMALS; CHROMATOGRAPHY, GEL; CHYLOMICRONS; DRUG COMPOUNDING; EMULSIONS; EXCIPIENTS; MICE; MICE, INBRED BALB C; NEUTRON CAPTURE THERAPY; ORGANOMETALLIC COMPOUNDS; PARTICLE SIZE; TISSUE DISTRIBUTION;

EID: 33644829424     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.09.004     Document Type: Article

References (46)

1. R.F. Barth, A.H. Soloway, Perspective on boron neutron capture therapy, Int. J. Radiat. Oncol. Biol. Phys. 28 (1994) 1059-1060.
2. J. Carlsson, E. Forssell-Aronsson, B. Glimelius, Radiation therapy through activation of stable nuclides, Acta Oncol. 41 (2002) 629-634.
3. A.H. Soloway, R.F. Barth, R.A. Gahbauer, T.E. Blue, J.H. Goodman, The rationale and requirements for the development of boron neutron capture therapy of brain tumors, J. Neurooncol. 33 (1997) 9-18.
4. R.F. Barth, A.H. Soloway, J.H. Goodman, R.A. Gahbauer, N. Gupta, T.E. Blue, W. Yang, W. Tjarks, Boron neutron capture therapy of brain tumors: an emerging therapeutic modality, Neurosurgery 44 (1999) 433-450; (discussion 450-431).
5. H.R. Blaumann, S.J. Gonzalez, J. Longhino, G.A. Santa Cruz, O.A. Calzetta Larrieu, M.R. Bonomi, B.M. Roth, Boron neutron capture therapy of skin melanomas at the RA-6 reactor: a procedural approach to beam set up and performance evaluation for upcoming clinical trials, Med. Phys. 31 (2004) 70-80.
6. R.F. Martin, G. D'Cunha, M. Pardee, B.J. Allen, Induction of DNA double-strand breaks by 157Gd neutron capture, Pigment. Cell Res. 2 (1989) 330-332.
7. H. Tokumitsu J. Hiratsuka Y. Sakurai T. Kobayashi H. Ichikawa Y. Fukumori Gadolinium Neutron-Capture Therapy Using Novel Qadopentetic Acid-Chitosan Complex Nanoparticles: In Vivo Growth Suppression of Experimental Melanoma Solid Tumor, 2000 177 182
8. M.O. Oyewumi, R.A. Yokel, M. Jay, T. Coakley, R.J. Mumper, Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J. Control. Release 95 (2004) 613-626.
9. J.L. Shih, R.M. Brugger, Gadolinium as a neutron capture therapy agent, Med. Phys., 19 (1992) 733-744.
10. R.M. Brugger, J.A. Shih, Evaluation of gadolinium-157 as a neutron capture therapy agent, Strahlenther Onkol. 165 (1989) 153-156.
11. S. Aime, A. Barge, C. Cabella, S.G. Crich, E. Gianolio, Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates, Curr. Pharm. Biotechnol. 5 (2004) 509-518.
12. S. Aime, C. Cabella, S. Colombatto, S. Geninatti Crich, E. Gianolio, F. Maggioni, Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations, J. Magn. Reson. Imaging 16 (2002) 394-406.
13. M. Miyamoto, H. Ichikawa, Y. Fukumori, Y. Akine, K. Tokuuye, Design and preparation of gadolinium-reservoir microcapsules for neutron-capture therapy by means of the Wurster process, Chem. Pharm. Bull. (Tokyo) 45 (1997) 2043-2050.
14. H. Tokumitsu, H. Ichikawa, Y. Fukumori, Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization, Pharm. Res. 16 (1999) 1830-1835.
15. H. Tokumitsu, H. Ichikawa, Y. Fukumori, L.H. Block, Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique, Chem. Pharm. Bull. (Tokyo), 47 (1999) 838-842.
16. M. Miyamoto, K. Hirano, H. Ichikawa, Y. Fukumori, Y. Akine, K. Tokuuye, Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron-capture therapy with tumor-bearing hamsters, Biol. Pharm. Bull. 22 (1999) 1331-1340.
17. M.O. Oyewumi, R.J. Mumper, Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles, Int. J. Pharm. 251 (2003) 85-97.
18. M.B. Bally, D. Masin, R. Nayar, P.R. Cullis, L.D. Mayer, Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice, Cancer Chemother. Pharmacol. 34 (1994) 137-146.
19. S.K. Hobbs, W.L. Monsky, F. Yuan, W.G. Roberts, L. Griffith, V.P. Torchilin, R.K. Jain, Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment, Proc. Natl Acad. Sci. USA, 95 (1998) 4607-4612.
20. R.K. Jain, Delivery of molecular and cellular medicine to solid tumors, Adv. Drug Deliv. Rev. 26 (1997) 71-90.
21. N.Z. Wu, D. Da, T.L. Rudoll, D. Needham, A.R. Whorton, M.W. Dewhirst, Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue, Cancer Res. 53 (1993) 3765-3770.
22. R.W. Mahley, T.L. Innerarity, Lipoprotein receptors and cholesterol homeostasis, Biochim. Biophys. Acta 737 (1983) 197-222.
23. P.C. Rensen, R.L. de Vrueh, J. Kuiper, M.K. Bijsterbosch, E.A. Biessen, T.J. van Berkel, Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting, Adv. Drug Deliv. Rev. 47 (2001) 251-276.
24. V.N. Schumaker, G.H. Adams, Circulating lipoproteins, Annu. Rev. Biochem. 38 (1969) 113-136.
25. T. Hara, Y. Tan, L. Huang, In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector, Proc. Natl Acad. Sci. USA, 94 (1997) 14547-14552.
26. E. Windler, Y. Chao, R.J. Havel, Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat, J. Biol. Chem. 255 (1980) 5475-5480.
27. R.J. Havel, Chylomicron remnants: hepatic receptors and metabolism, Curr. Opin. Lipidol. 6 (1995) 312-316.
28. P.C. Rensen, M.C. van Dijk, E.C. Havenaar, M.K. Bijsterbosch, J.K. Kruijt, T.J. van Berkel, Selective liver targeting of antivirals by recombinant chylomicrons-a new therapeutic approach to hepatitis B, Nat. Med. 1 (1995) 221-225.
29. M. Huettinger, H. Retzek, M. Eder, H. Goldenberg, Characteristics of chylomicron remnant uptake into rat liver, Clin. Biochem. 21 (1988) 87-92.
30. E. Windler, Y. Chao, R.J. Havel, Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins, J. Biol. Chem. 255 (1980) 8303-8307.
31. T.J. Van Berkel, J.K. Kruijt, L.M. Scheek, P.H. Groot, Effect of apolipoproteins E and C-III on the interaction of chylomicrons with parenchymal and non-parenchymal cells from rat liver, Biochem. J. 216 (1983) 71-80.
32. C. Monfardini, F.M. Veronese, Stabilization of substances in circulation, Bioconjug. Chem. 9 (1998) 418-450.
33. T. Yuda, K. Maruyama, M. Iwatsuru, Prolongation of liposome circulation time by various derivatives of polyethyleneglycols, Biol. Pharm. Bull. 19 (1996) 1347-1351.
34. K. Maruyama, T. Takizawa, T. Yuda, S.J. Kennel, L. Huang, M. Iwatsuru, Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies, Biochim. Biophys. Acta 1234 (1995) 74-80.
35. S.M. Moghimi, I.S. Muir, L. Illum, S.S. Davis, V. Kolb-Bachofen, Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum, Biochim. Biophys. Acta 1179 (1993) 157-165.
36. K. Maruyama, T. Yuda, A. Okamoto, S. Kojima, A. Suginaka, M. Iwatsuru, Prolonged circulation time in vivo of large unilamelar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol), Biochim. Biophys. Acta 1128 (1992) 44-49.
37. S. Simoes, J.N. Moreira, C. Fonseca, N. Duzgunes, M.C. de Lima, On the formulation of pH-sensitive liposomes with long circulation times, Adv. Drug Deliv. Rev. 56 (2004) 947-965.
38. M.C. Woodle, D.D. Lasic, Sterically stabilized liposomes, Biochim. Biophys. Acta 1113 (1992) 171-199.
39. E.G. Bligh, W.J. Dyer, A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol., 37 (1959) 911-917.
40. M.O. Oyewumi, R.J. Mumper, Gadolinium-loaded nanoparticles engineered from microemulsion templates, Drug Dev. Ind. Pharm. 28 (3) (2002) 317-328.
41. F.C. MacLaughlin, R.J. Mumper, J. Wang, J.M. Tagliaferri, I. Gill, M. Hinchcliffe, A.P. Rolland, Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, J. Control. Release, 56 (1-3) (1998) 259-272.
42. E.M. Frame, E.E. Uzgiris, Gadolinium determination in tissue samples by inductively coupled plasma mass spectrometry and inductively coupled plasma atomic emission spectrometry in evaluation of the action of magnetic resonance imaging contrast agents, Analyst 123 (1998) 675-679.
43. K. Jono, H. Ichikawa, K. Fujioka, Y. Fukumori, Y. Akine, K. Tokuuye, Preparation of lecithin microcapsules by a dilution method using the Wurster process for intraarterial administration in gadolinium neutron capture therapy, Chem. Pharm. Bull. (Tokyo), 47 (1999) 54-63.
44. S.R. Tamat, D.E. Moore, B.J. Allen, Determination of boron in biological tissues by inductively coupled plasma atomic emission spectrometry, Anal. Chem. 59 (1987) 2161-2164.
45. Y. Akine, N. Tokita, K. Tokuuye, M. Satoh, H. Churei, C. Le Pechoux, T. Kobayashi, K. Kanda, Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy, Jpn. J. Cancer Res. 84 (1993) 841-843.
46. M.O. Oyewumi, R.J. Mumper, Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy, Bioconjug. Chem. 13 (2002) 1328-1335.